Given the already known role of NCOA4 in ferritin degradation, targeting the COPZ1/NCOA4/FTH1 axis may be a promising therapeutic strategy for the treatment of human glioblastoma (GBM) [8]. Here, NCOA4 is linked to glioblastoma.